🇺🇸 FDA
Patent

US 7563930

Crystal forms of Cinacalcet HCI and processes for their preparation

granted A61KA61K31/137A61P

Quick answer

US patent 7563930 (Crystal forms of Cinacalcet HCI and processes for their preparation) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Jul 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEVA PHARMACEUTICAL INDUSTRIES, LTD.
Grant date
Tue Jul 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
37
CPC classes
A61K, A61K31/137, A61P, A61P13/12, A61P19/08